William E.: Rho-Kinase Identified as a Novel Target in Post-COVID-19 Vascular Disease
William E. shared a post on LinkedIn about a recent article by Robert A Sykes et al. published in European Heart Journal – Cardiovascular Pharmacotherapy:
“Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy.”
Article: Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy
Authors: Robert A Sykes, Karla B Neves, Rhéure Alves-Lopes, Ilaria Caputo, Kirsty Fallon, Nigel B Jamieson, Anna Kamdar, Assya Legrini, Holly Leslie, Alasdair McIntosh, Alex McConnachie, Andrew Morrow, Richard W McFarlane, Kenneth Mangion, John McAbney, Augusto C Montezano, Rhian M Touyz, Colin Wood, Colin Berry
Read the Full Article on European Heart Journal – Cardiovascular Pharmacotherapy
Stay updated with Hemostasis Today.
-
May 7, 2026, 07:48Could Albuminuria Be an Overlooked Marker of Thrombotic Risk? – RPTH Journal
-
May 7, 2026, 07:37Matías J Alet: On the Implementation of Tenecteplase for Acute Ischemic Stroke at ESOC 2026
-
May 7, 2026, 07:21Britta Diebel: Reflections on Healthcare Impact from the PPTA IPPC Congress
-
May 7, 2026, 07:02Ana Cláudia de Souza: NeuroLeadership, Management and Behavioural Insights in Stroke Care from ESOC 2026
-
May 7, 2026, 07:00Maxime Dely: Just 60 Minutes of Our Time to Help a Patient We Will Never Meet
-
May 7, 2026, 06:37Anagha Kulkarni: Insights and A Prize from ISBMT Annual Conference 2026
-
May 7, 2026, 06:37Neelmani Singh: Why Iron Deficiency Is a Brain Health Issue
-
May 7, 2026, 06:25Vivek Sinha: The Science Behind a CBC Test
-
May 7, 2026, 06:17Emily Brown: Honor to Represent Hemophilia of Georgia at 2026 World Federation of Hemophilia Congress